Biomerica (BMRA) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Biomerica (BMRA) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | -54.61% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -1,294.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1,294.55% |
| Nov 30, 2025 | 83.31% |
| Aug 31, 2025 | 20.05% |
| May 31, 2025 | 0.98% |
| Feb 28, 2025 | -2,071.02% |
| Nov 30, 2024 | -49.97% |
| Aug 31, 2024 | -7.34% |
| May 31, 2024 | -61.77% |
| Feb 29, 2024 | -70.48% |
| Nov 30, 2023 | -74.87% |
| Aug 31, 2023 | 41.17% |
| May 31, 2023 | -85.50% |
| Feb 28, 2023 | -7,478.55% |
| Nov 30, 2022 | -6,087.78% |
| Aug 31, 2022 | -9,628.73% |
| May 31, 2022 | 99.96% |
| Feb 28, 2022 | 96.77% |
| Nov 30, 2021 | 60.88% |
| Aug 31, 2021 | 95.80% |
| Feb 28, 2021 | -58.40% |